A LinkedIn post from Formlabs highlights the use of its Form 4 printer and high-performance resins in producing components for PSYONIC’s Ability Hand, which is described as one of the fastest bionic hands on the market. The post frames the device as improving performance and accessibility in prosthetics, underscoring a human-impact narrative around additive manufacturing.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
For investors, the content suggests Formlabs is gaining traction in advanced medical and prosthetics applications, a segment that can command premium pricing and recurring materials demand. Demonstrated use in a sophisticated bionic device may strengthen the company’s positioning in healthcare-focused 3D printing, support brand differentiation versus competitors, and signal potential for deeper collaborations in the medical device value chain.
If this type of application scales, Formlabs could see increased revenue from both hardware and consumables as medical and prosthetics providers adopt 3D printing workflows. The focus on performance and accessibility also aligns with broader trends toward personalized medical solutions, which may enhance the company’s long-term growth prospects in regulated, higher-margin verticals, though the post does not provide quantitative metrics or financial guidance.